Statistics for Hyloris Pharmaceuticals SA (id:380 HYL)
Valuation metrics
Market cap
140.56M
Enterprise value
119.72M
Trailing P/E (ttm)
-9.49
Forward P/E
-8.28
PEG ratio
3.00
Price/Sales (ttm)
20.25
Price/Book (mrq)
4.21
Enterprise Value/Revenue
17.25
Enterprise Value/EBITDA
-8.85
Overview
Shares outstanding
28.00M
Float
12.54M
Shares short
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
29.76K
Average volume (90 days)
Price summary
52-Week low
2.89
52-Week high
13.30
52-Week change
-141.57%
Beta
3.00
50-Day moving average
5.53
200-Day moving average
9.13
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
December 31, 2023
Profitability
Profit margin
-190.79%
Operating margin
-84.72%
Operational effectiveness
Return on assets
-16.75%
Return on equity
-31.76%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
1.99M
EBITDA
-13,525,000.00
Net income to common (ttm)
-13,243,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
27.96M
Total cash per share (mrq)
3.00
Total debt (mrq)
1.89M
Total Debt/Equity (mrq)
5.44
Current ratio (mrq)
371.10%
Book value per share (mrq)
1.19
Cash flow
Cash flow statement
-12,015,000.00
Levered free cash flow (LFCF)
-6,919,875.00